Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPembroke Vct Regulatory News (PEMB)

Share Price Information for Pembroke Vct (PEMB)

Share Price is delayed by 15 minutes
Get Live Data
92.00    0.00 (0.00%)
Bid:
90.00
Ask:
94.00
Spread: 4.00 (4.444%)
Market Cap: £269.20m
PEMB Live PriceLast checked at - London Stock Exchange

Intraday Pembroke Vct Share Chart

Annual Financial Report

28 Jun 2022 18:15

RNS Number : 5433Q
Pembroke VCT PLC
28 June 2022
 

Pembroke VCT plc (the "Company")

 

Annual Report & Financial Statements for the year ended 31 March 2022;

Notice of Dividend; &

Share Buyback Programme

 

Results announcement

The Company's directors ("Directors") are pleased to attach the Company's annual report and financial statements for the year ended 31 March 2022. The highlights Include:

 

· Net asset value total return per share of 151.0p (+13% in the year and +24% over two years)

· Net asset value per share of 126.0p

· £200m fund size; an increase of 50% on last year

· £19.1m to shareholders in the year to March 2022 through dividends and share buyback, and

· 7.0p per share in dividends in each of the last two financial years.

 

 Click on, or paste the following link into your web browser, to view the associated PDF document:

 

http://www.rns-pdf.londonstockexchange.com/rns/5433Q_1-2022-6-28.pdf

 

The annual report and financial statements for the year ended 31 March 2022 may also be downloaded from the Company's website at www.pembrokevct.com.

 

Notice of dividend

The Company has declared a 5.0p per share interim dividend (£8.3m). The record date is 8 July 2022, the ex-dividend date is 7 July 2022 and the payment date is 29 July 2022. The last date for receipt of elections in respect of the interim dividend under the Company's dividend re-investment scheme is 15 July 2022.

 

The Directors are pleased to announce their decision to increase the average annual dividend payment per share target from 3.0p per share to 5.0p per share with effect from the year ending 31 March 2023.

 

Share buyback programme

The VCT rules allow £44m of the Company's special reserves to become distributable in April 2023. Accordingly, the Board intends a share buyback in April 2023 and will consider further share buybacks every six months thereafter.

 

 

For further details about the Company please either visit the Company's website:

 

Pembroke VCT plc

www.pembrokevct.com 

 

or contact:

 

Andrew Wolfson / Chris Lewis

Pembroke Investment Managers LLP (Manager)

+44 20 7766 6900

 

Robin Smeaton

The City Partnership (UK) Limited (Company Secretary)

enquiries@city.uk.com

 

Keith Lassman

Howard Kennedy Corporate Services LLP

+44 20 3755 5561

 

Seven Hills PR

Gary O'Sullivan

0781 790 3406

gary.osullivan@wearesevenhills.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACSEAXKPAFDAEFA
Date   Source Headline
29th May 20264:00 pmRNSTotal Voting Rights
29th May 202610:30 amRNSIssue of Equity
28th May 202612:30 pmRNSNotification of Admission of Shares
11th May 20267:00 amRNSClose of Offer to Further Applications
30th Apr 20264:00 pmRNSNotification of Admission of Shares and TVR
30th Apr 202610:30 amRNSIssue of Equity
22nd Apr 20261:00 pmRNSPurchase of Own Securities
10th Apr 202612:10 pmRNSIssue of Equity
31st Mar 20261:30 pmRNSTotal Voting Rights
31st Mar 20261:05 pmRNSUtilisation of over-allotment facility
31st Mar 20269:00 amRNSIssue of Equity
6th Mar 202611:16 amRNSDirector/PDMR Shareholding
6th Mar 202611:15 amRNSDirector/PDMR Shareholding
6th Mar 202611:12 amRNSDirector/PDMR Shareholding
5th Mar 202610:07 amRNSIssue of Equity
27th Feb 20269:00 amRNSNotification of Admission of Shares and TVR
13th Feb 20269:00 amRNSIssue of Equity
11th Feb 20261:09 pmRNSNet Asset Value
30th Jan 20267:00 amRNSNotification of Admission of Shares and TVR
20th Jan 20269:00 amRNSIssue of Equity
13th Jan 20267:00 amRNSDirectorate change
31st Dec 20257:00 amRNSTotal Voting Rights
31st Dec 20257:00 amRNSTotal Voting Rights
16th Dec 20252:15 pmRNSIssue of Equity and TVR
28th Nov 20257:00 amRNSTotal Voting Rights
21st Nov 20259:16 amRNSDirector/PDMR Shareholding
21st Nov 20259:15 amRNSDirector/PDMR Shareholding
21st Nov 20259:00 amRNSIssue of Equity
17th Nov 20253:15 pmRNSHalf-Year Report
13th Nov 202510:29 amRNSChange of Registered Office
12th Nov 20254:44 pmRNSDividend Declaration
23rd Oct 202512:25 pmRNSIssue of Equity and TVR
25th Sep 20255:42 pmRNSResult of AGM
19th Sep 20255:19 pmRNSPurchase of Own Securities
9th Sep 20253:51 pmRNSPublication of Prospectus
21st Aug 202510:40 amRNSNet Asset Value per Share as at 30 June 2025
25th Jun 20252:15 pmRNSAnnual Financial Report - Replacement
25th Jun 202512:51 pmRNSIntention to Launch an Offer for Subscription
25th Jun 202512:47 pmRNSAnnual Financial Report
27th May 202512:07 pmRNSIssue of Equity
24th Apr 20252:35 pmRNSIssue of Equity
15th Apr 20255:46 pmRNSDirector/PDMR Shareholding
7th Apr 202512:43 pmRNSDirector/PDMR Shareholding
7th Apr 202512:43 pmRNSDirector/PDMR Shareholding
7th Apr 20257:00 amRNSIssue of Equity
31st Mar 20256:10 pmRNSIssue of Equity
20th Mar 202512:19 pmRNSDirector/PDMR Shareholding
20th Mar 202512:18 pmRNSDirector/PDMR Shareholding
19th Mar 202511:40 amRNSIssue of Equity
12th Mar 20257:00 amRNSDividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.